Literature DB >> 32666584

Induction of labour at or beyond 37 weeks' gestation.

Philippa Middleton1, Emily Shepherd1,2, Jonathan Morris3, Caroline A Crowther4, Judith C Gomersall5.   

Abstract

BACKGROUND: Risks of stillbirth or neonatal death increase as gestation continues beyond term (around 40 weeks' gestation). It is unclear whether a policy of labour induction can reduce these risks. This Cochrane Review is an update of a review that was originally published in 2006 and subsequently updated in 2012 and 2018.
OBJECTIVES: To assess the effects of a policy of labour induction at or beyond 37 weeks' gestation compared with a policy of awaiting spontaneous labour indefinitely (or until a later gestational age, or until a maternal or fetal indication for induction of labour arises) on pregnancy outcomes for the infant and the mother. SEARCH
METHODS: For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (ICTRP) (17 July 2019), and reference lists of retrieved studies. SELECTION CRITERIA: Randomised controlled trials (RCTs) conducted in pregnant women at or beyond 37 weeks, comparing a policy of labour induction with a policy of awaiting spontaneous onset of labour (expectant management). We also included trials published in abstract form only. Cluster-RCTs, quasi-RCTs and trials using a cross-over design were not eligible for inclusion in this review. We included pregnant women at or beyond 37 weeks' gestation. Since risk factors at this stage of pregnancy would normally require intervention, only trials including women at low risk for complications, as defined by trialists, were eligible. The trials of induction of labour in women with prelabour rupture of membranes at or beyond term were not considered in this review but are considered in a separate Cochrane Review. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trials for inclusion, assessed risk of bias and extracted data. Data were checked for accuracy. We assessed the certainty of evidence using the GRADE approach. MAIN
RESULTS: In this updated review, we included 34 RCTs (reporting on over 21,000 women and infants) mostly conducted in high-income settings. The trials compared a policy to induce labour usually after 41 completed weeks of gestation (> 287 days) with waiting for labour to start and/or waiting for a period before inducing labour. The trials were generally at low to moderate risk of bias. Compared with a policy of expectant management, a policy of labour induction was associated with fewer (all-cause) perinatal deaths (risk ratio (RR) 0.31, 95% confidence interval (CI) 0.15 to 0.64; 22 trials, 18,795 infants; high-certainty evidence). There were four perinatal deaths in the labour induction policy group compared with 25 perinatal deaths in the expectant management group. The number needed to treat for an additional beneficial outcome (NNTB) with induction of labour, in order to prevent one perinatal death, was 544 (95% CI 441 to 1042). There were also fewer stillbirths in the induction group (RR 0.30, 95% CI 0.12 to 0.75; 22 trials, 18,795 infants; high-certainty evidence); two in the induction policy group and 16 in the expectant management group. For women in the policy of induction arms of trials, there were probably fewer caesarean sections compared with expectant management (RR 0.90, 95% CI 0.85 to 0.95; 31 trials, 21,030 women; moderate-certainty evidence); and probably little or no difference in operative vaginal births with induction (RR 1.03, 95% CI 0.96 to 1.10; 22 trials, 18,584 women; moderate-certainty evidence). Induction may make little or difference to perineal trauma (severe perineal tear: RR 1.04, 95% CI 0.85 to 1.26; 5 trials; 11,589 women; low-certainty evidence). Induction probably makes little or no difference to postpartum haemorrhage (RR 1.02, 95% CI 0.91 to 1.15, 9 trials; 12,609 women; moderate-certainty evidence), or breastfeeding at discharge (RR 1.00, 95% CI 0.96 to 1.04; 2 trials, 7487 women; moderate-certainty evidence). Very low certainty evidence means that we are uncertain about the effect of induction or expectant management on the length of maternal hospital stay (average mean difference (MD) -0.19 days, 95% CI -0.56 to 0.18; 7 trials; 4120 women; Tau² = 0.20; I² = 94%). Rates of neonatal intensive care unit (NICU) admission were lower (RR 0.88, 95% CI 0.80 to 0.96; 17 trials, 17,826 infants; high-certainty evidence), and probably fewer babies had Apgar scores less than seven at five minutes in the induction groups compared with expectant management (RR 0.73, 95% CI 0.56 to 0.96; 20 trials, 18,345 infants; moderate-certainty evidence). Induction or expectant management may make little or no difference for neonatal encephalopathy (RR 0.69, 95% CI 0.37 to 1.31; 2 trials, 8851 infants; low-certainty evidence, and probably makes little or no difference for neonatal trauma (RR 0.97, 95% CI 0.63 to 1.49; 5 trials, 13,106 infants; moderate-certainty evidence) for induction compared with expectant management. Neurodevelopment at childhood follow-up and postnatal depression were not reported by any trials. In subgroup analyses, no differences were seen for timing of induction (< 40 versus 40-41 versus > 41 weeks' gestation), by parity (primiparous versus multiparous) or state of cervix for any of the main outcomes (perinatal death, stillbirth, NICU admission, caesarean section, operative vaginal birth, or perineal trauma). AUTHORS'
CONCLUSIONS: There is a clear reduction in perinatal death with a policy of labour induction at or beyond 37 weeks compared with expectant management, though absolute rates are small (0.4 versus 3 deaths per 1000). There were also lower caesarean rates without increasing rates of operative vaginal births and there were fewer NICU admissions with a policy of induction. Most of the important outcomes assessed using GRADE had high- or moderate-certainty ratings. While existing trials have not yet reported on childhood neurodevelopment, this is an important area for future research. The optimal timing of offering induction of labour to women at or beyond 37 weeks' gestation needs further investigation, as does further exploration of risk profiles of women and their values and preferences. Offering women tailored counselling may help them make an informed choice between induction of labour for pregnancies, particularly those continuing beyond 41 weeks - or waiting for labour to start and/or waiting before inducing labour.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2020        PMID: 32666584      PMCID: PMC7389871          DOI: 10.1002/14651858.CD004945.pub5

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  132 in total

1.  Use of misoprostol on an outpatient basis for postdate pregnancy.

Authors:  J H Kipikasa; C D Adair; J Williamson; J M Breen; L K Medford; L Sanchez-Ramos
Journal:  Int J Gynaecol Obstet       Date:  2004-12-28       Impact factor: 3.561

2.  The influence of nipple stimulation at term on the duration of pregnancy.

Authors:  N Kadar; A Tapp; A Wong
Journal:  J Perinatol       Date:  1990-06       Impact factor: 2.521

3.  Maternal and newborn outcomes with elective induction of labor at term.

Authors:  Vivienne Souter; Ian Painter; Kristin Sitcov; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2019-02-17       Impact factor: 8.661

4.  A randomised double-blind study of vaginal misoprostol vs dinoprostone for cervical ripening and labour induction in prolonged pregnancy.

Authors:  H Y Lee
Journal:  Singapore Med J       Date:  1997-07       Impact factor: 1.858

5.  Maternal risk factors for postterm pregnancy and cesarean delivery following labor induction.

Authors:  Nathalie Roos; Lena Sahlin; Gunvor Ekman-Ordeberg; Helle Kieler; Olof Stephansson
Journal:  Acta Obstet Gynecol Scand       Date:  2010-08       Impact factor: 3.636

6.  A randomized trial of induction at 42 weeks gestation versus expectant management for postdates pregnancies.

Authors:  F R Witter; C M Weitz
Journal:  Am J Perinatol       Date:  1987-07       Impact factor: 1.862

7.  Induction of labour versus expectant management for nulliparous women over 35 years of age: a multi-centre prospective, randomised controlled trial.

Authors:  Kate F Walker; George Bugg; Marion Macpherson; Carol McCormick; Chris Wildsmith; Gordon Smith; Jim Thornton
Journal:  BMC Pregnancy Childbirth       Date:  2012-12-11       Impact factor: 3.007

8.  Genes and post-term birth: late for delivery.

Authors:  William Schierding; Justin M O'Sullivan; José G B Derraik; Wayne S Cutfield
Journal:  BMC Res Notes       Date:  2014-10-14

Review 9.  Maternal body mass index and post-term birth: a systematic review and meta-analysis.

Authors:  N Heslehurst; R Vieira; L Hayes; L Crowe; D Jones; S Robalino; E Slack; J Rankin
Journal:  Obes Rev       Date:  2017-01-13       Impact factor: 9.213

10.  Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.

Authors:  Judit Kj Keulen; Aafke Bruinsma; Joep C Kortekaas; Jeroen van Dillen; Patrick Mm Bossuyt; Martijn A Oudijk; Ruben G Duijnhoven; Anton H van Kaam; Frank Pha Vandenbussche; Joris Am van der Post; Ben Willem Mol; Esteriek de Miranda
Journal:  BMJ       Date:  2019-02-20
View more
  22 in total

1.  New Markers for Placental Dysfunction at Term - Potential for More.

Authors:  Oliver Graupner; Bettina Kuschel; Roland Axt-Fliedner; Christian Enzensberger
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-07-07       Impact factor: 2.754

2.  Breaking the myth: the association between the increasing incidence of labour induction and the rate of caesarean delivery in Finland - a nationwide Medical Birth Register study.

Authors:  Heidi Kruit; Mika Gissler; Seppo Heinonen; Leena Rahkonen
Journal:  BMJ Open       Date:  2022-07-04       Impact factor: 3.006

3.  Prediction of spontaneous onset of labor at term (PREDICT study): Research protocol.

Authors:  Federico Migliorelli; Ludovica Ferrero; Catherine McCarey; Sara Marcenaro; Véronique Othenin-Girard; Antonina Chilin; Begoña Martinez de Tejada
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

4.  Elective induction of labour and expectant management in late-term pregnancy: A prospective cohort study alongside the INDEX randomised controlled trial.

Authors:  Aafke Bruinsma; Judit Kj Keulen; Joep C Kortekaas; Jeroen van Dillen; Ruben G Duijnhoven; Patrick Mm Bossuyt; Anton H van Kaam; Joris Am van der Post; Ben W Mol; Esteriek de Miranda
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2022-10-03

5.  Induction of labour at or beyond 37 weeks' gestation.

Authors:  Philippa Middleton; Emily Shepherd; Jonathan Morris; Caroline A Crowther; Judith C Gomersall
Journal:  Cochrane Database Syst Rev       Date:  2020-07-15

Review 6.  American College of Nurse-Midwives Clinical Bulletin Number 18: Induction of Labor.

Authors:  Nicole Smith Carlson; Alexis Dunn Amore; Jessica Ann Ellis; Katie Page; Robyn Schafer
Journal:  J Midwifery Womens Health       Date:  2022-01       Impact factor: 2.891

7.  Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.

Authors:  Mårten Alkmark; Judit K J Keulen; Joep C Kortekaas; Christina Bergh; Jeroen van Dillen; Ruben G Duijnhoven; Henrik Hagberg; Ben Willem Mol; Mattias Molin; Joris A M van der Post; Sissel Saltvedt; Anna-Karin Wikström; Ulla-Britt Wennerholm; Esteriek de Miranda
Journal:  PLoS Med       Date:  2020-12-08       Impact factor: 11.069

8.  Oxytocin Administration in Low-Risk Women, a Retrospective Analysis of Birth and Neonatal Outcomes.

Authors:  Xavier Espada-Trespalacios; Felipe Ojeda; Mercedes Perez-Botella; Raimon Milà Villarroel; Montserrat Bach Martinez; Helena Figuls Soler; Israel Anquela Sanz; Pablo Rodríguez Coll; Ramon Escuriet
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

9.  Feasibility study protocol of a pragmatic, randomised controlled pilot trial: membrane sweeping to prevent post-term pregnancy-the MILO Study.

Authors:  Elaine M Finucane; Linda Biesty; Deirdre Murphy; Amanda Cotter; Eleanor Molloy; Martin O'Donnell; Shaun Treweek; Paddy Gillespie; Marian Campbell; John J Morrison; Alberto Alvarez-Iglesias; Gill Gyte; Declan Devane
Journal:  Trials       Date:  2021-02-02       Impact factor: 2.279

10.  Proportion and Outcome of Induction of Labor Among Mothers Who Delivered in Teaching Hospital, Southwest Ethiopia.

Authors:  Tewodros Yosef; Dawit Getachew
Journal:  Front Public Health       Date:  2021-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.